Amir Vahabzadeh sold $5,667 of STME
director, owner at Cell MedX Corp.. 16,667 shares at an average of $0.34, traded Dec 18, 2025, filed Dec 19, 2025.
Score components
- +15RoleDirector
- 0Trade size$6k at market
- 0Share of holdings soldSold 0.4% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +18.3%, 3m -23.1%, 6m -10.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001504213-25-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 18, 2025 | SOpen-market sale Common Shares | +16,667 | $0.34 | $5,667 | 4,164,566 | Dec 19, 2025 |
Related signals
Other insiders at Cell MedX Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 7Weak | STMEbuy Cell MedX Corp. | Richard Jeffs owner | $3,310 19,399 shares | +1% | |
| 57Moderate | Cell MedX Corp. | David Jeffs Chief Executive Officer | $105k 15,000,000 shares | +20% | |
| 43Moderate | Cell MedX Corp. | Richard Jeffs owner | $101k 14,372,285 shares | +128% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.